CLGN CollPlant Biotechnologies

NASDAQ
$3.50

CollPlant Biotechnologies (CLGN) SEC Filings

Everything CLGN has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

8 filings
Date Form Filing
4
4
6-K Acquisition Disposition · Executive Change
6-K Acquisition Disposition
6-K Acquisition Disposition · Delisting · Other
6-K Acquisition Disposition · Executive Change · Material Agreement
SCHEDULE 13D/A
6-K

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.